Vulcan Value Partners Cut Ituran Location And Control (ITRN) Holding By $32.41 Million; Shorts at Soleno Therapeutics (SLNO) Raised By 9.84%

March 13, 2018 - By Darrin Black

Vulcan Value Partners Llc decreased Ituran Location And Control (ITRN) stake by 26.37% reported in 2017Q3 SEC filing. Vulcan Value Partners Llc sold 900,334 shares as Ituran Location And Control (ITRN)’s stock rose 13.25%. The Vulcan Value Partners Llc holds 2.51 million shares with $90.62 million value, down from 3.41M last quarter. Ituran Location And Control now has $749.61M valuation. The stock decreased 0.42% or $0.15 during the last trading session, reaching $35.75. About 33,124 shares traded. Ituran Location and Control Ltd. (NASDAQ:ITRN) has risen 53.77% since March 13, 2017 and is uptrending. It has outperformed by 37.07% the S&P500.

Soleno Therapeutics Inc (NASDAQ:SLNO) had an increase of 9.84% in short interest. SLNO’s SI was 70,300 shares in March as released by FINRA. Its up 9.84% from 64,000 shares previously. With 151,700 avg volume, 1 days are for Soleno Therapeutics Inc (NASDAQ:SLNO)’s short sellers to cover SLNO’s short positions. The SI to Soleno Therapeutics Inc’s float is 2.29%. The stock increased 1.06% or $0.02 during the last trading session, reaching $1.91. About 27,590 shares traded. Soleno Therapeutics, Inc. (NASDAQ:SLNO) has 0.00% since March 13, 2017 and is . It has underperformed by 16.70% the S&P500.

Soleno Therapeutics, Inc. focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company has market cap of $36.75 million. The companyÂ’s lead candidate, diazoxide choline controlled-release , a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is entering into Phase II/III clinical development. It currently has negative earnings. It also markets medical devices, including the CoSense End-Tidal Carbon Monoxide (ETCO) monitor, which measures ETCO and is used by hospitals to detect hemolysis in newborns; and NeoPip T-piece resuscitator and related consumables, which deliver consistent pre-set inspiratory pressure and positive end-expiratory pressures, as well as temperature probes, scales, surgical tables, and patient surfaces.

Vulcan Value Partners Llc increased Amerisourcebergen Corp (NYSE:ABC) stake by 553,857 shares to 5.82 million valued at $481.58M in 2017Q3. It also upped United Technologies Corp (NYSE:UTX) stake by 346,581 shares and now owns 910,077 shares. Mckesson Corp (NYSE:MCK) was raised too.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: